Next, we found that the ccRCC patients with high tumor stage (Stage II and III) (case 2 in Figure 6A) showed increased protein levels of ST3GAL5, CD8 and PD-1, compared to those with low tumor stage (Stage I) (case 1 in Figure 6A). This evidence concerns the gene PDCD1 and neoplasm.